AA
TAK icon

Ancora Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Ancora Advisors’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6K Sell
1,413
-406
-22% -$6.72K ﹤0.01% 1284
2026
Q1 		$33.7K Buy
1,819
+406
+29% +$7.13K ﹤0.01% 1313
2025
Q4 		$22K Hold
1,413
– – ﹤0.01% 1511
2025
Q3 		$20.7K Hold
1,413
– – ﹤0.01% 1233
2025
Q2 		$21.8K Buy
+1,413
New +$20.9K ﹤0.01% 1207

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Ancora Advisors's TAK Position: Q2 2026 in Review

Ancora Advisors reduced its Takeda Pharmaceutical (TAK) stake by 22% in Q2 2026, selling an estimated $6.72K and leaving 1,413 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1284.

Ancora Advisors first reported a position in TAK in Q2 2025 and has held it in 5 quarters since. The position peaked at $33.7K in Q1 2026. 375 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Ancora Advisors held 1,413 shares of Takeda Pharmaceutical worth $22.6K as of Q2 2026.
  • Ancora Advisors sold 406 Takeda Pharmaceutical shares in Q2 2026, an estimated $6.72K.
  • Takeda Pharmaceutical made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1284 holding.
  • Ancora Advisors first reported a position in Takeda Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • Ancora Advisors's Takeda Pharmaceutical position peaked at $33.7K in Q1 2026.
  • 375 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.